# Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.

> **NCT01080638** · PHASE4 · TERMINATED · sponsor: **Seoul National University Hospital** · enrollment: 150 (actual)

## Conditions studied

- Myocardial Infarction
- Angioplasty

## Interventions

- **DRUG:** glycoprotein IIb/IIIa inhibitor (abciximab)

## Key facts

- **NCT ID:** NCT01080638
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01080638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01080638, "Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01080638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*